Please ensure Javascript is enabled for purposes of website accessibility

Manning Institute of Biotechnology

AstraZeneca CEO Pascal Soriot speaks at the pharma company’s Albemarle County groundbreaking ceremony in October 2025. Photo by Kaitlyn DeHarde, Office of Gov. Glenn Youngkin
Apr 29, 2026

Charlottesville, Albemarle region prepare for biotech boost

AstraZeneca’s $4.5 billion investment in Albemarle County is set to create 600 jobs and strengthen Charlottesville’s biotech industry cluster.

PAUL MANNING
Mar 1, 2026

2026 Virginia Power 50 List: PAUL B. MANNING

CHAIRMAN AND CEO PBM CAPITAL GROUP CHARLOTTESVILLE

Rendering of the Manning Institute of Biotechnology's building at the Fontaine Research Park in Charlottesville. Image courtesy University of Virginia
Jun 26, 2025

UVA Health receives $50M in two anonymous gifts for Manning Institute

Two anonymous donors have given $25 million gifts to support the University of Virginia's Manning Institute of Biotechnology.

Mark T. Esser is the incoming head of the University of Virginia's Manning Institute of Biotechnology. Photo courtesy UVA Health
Apr 10, 2025

U.Va. hires AstraZeneca exec to lead Manning biotech institute

Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and Diane Manning Institute of Biotechnology at the University of Virginia, U.Va. announced Thursday. Esser, who will join U.Va. May 1, earned a Ph.D. in microbiology in 1998 from […]

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.